CURRENT NEWS

• 16.10.2019
  Abbott Reports Third-quarter 2019 Results
• 16.10.2019
  Syapse Appoints Dr. Thomas D. Brown as Chief Medical Officer
• 16.10.2019
  Atossa Genetics Receives IRB Approval For Phase 2 Breast Cancer Study Using Intraductal Technology
• 16.10.2019
  StemoniX Appoints Andrew D. C. LaFrence as Chief Financial Officer
• 16.10.2019
  Apexigen's CEO, Xiaodong Yang, Recognized Among 100 Most Intriguing Entrepreneurs at Goldman Sachs 2019 Builders + Innovators Summit
• 15.10.2019
  Aphria Inc. Announces Second Consecutive Quarter of Profitability and Positive Adjusted EBITDA
• 15.10.2019
  OTC Markets Group Welcomes Avicanna Inc. To OTCQX
• 15.10.2019
  Discovery Life Sciences Becomes Global Center of Excellence for PacBio Long-Read Genomic Sequencing
• 15.10.2019
  LabCorp Celebrates 50 Years of Improving Health, Improving Lives
• 15.10.2019
  CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies' Respective Cell Therapy Programs in Oncology
• 15.10.2019
  Checkmate Pharmaceuticals Announces Additions to Management Team
• 15.10.2019
  Co-Diagnostics Expands Vector Control Marketing Nationwide
• 15.10.2019
  Avivagen Announces Proposed Extension of Warrants
• 15.10.2019
  Can-Fite Completes Patient Enrollment in Phase II NASH Study of Namodenoson
• 15.10.2019
  Aura Biosciences Announces Updated Phase 1b/2 Clinical Data for AU-011 Presented at the American Academy of Ophthalmology 2019 Annual Meeting
• 15.10.2019
  DBV Technologies Announces Closing of Global Offering
• 15.10.2019
  Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
• 15.10.2019
  Fluidigm Showcases RNA Sequencing Innovations Using Microfluidics Technology at the 2019 American Society of Human Genetics (ASHG) Meeting
• 15.10.2019
  ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
• 15.10.2019
  ProQR Receives Rare Pediatric Disease Designation From FDA for Sepofarsen for the Treatment of LCA10

Records per page:

Page

Total: 40449 records.